AIDs organization lifts Abbott ban


A boycott of Abbott Laboratories by the Center for AIDS Information & Advocacy, a local HIV/AIDS organization, that began two years ago is being lifted. According to the press release:

    The boycott was part of a broad effort across the nation by community organizations, physicians, and other groups and included refusal to attend Abbott-sponsored programs, participate in company invitational meetings, accept financial donations, and more. The efforts against Abbott also included several lawsuits, on-site protests, and even a hearing at the US Food and Drug Administration in 2004 to consider releasing ritonavir‘s patent...

    In a letter addressed to Abbott, Gegeny states that his organization is lifting its two-year boycott of the pharmaceutical company in light of recent good-faith efforts by the company toward the HIV/AIDS community including:

    • The prompt donation of needed monies and pharmaceutical products to victims of hurricanes Katrina and Rita, as well as relief organizations in the affected areas.

    • A 2005 price increase for Abbott‘s Kaletra (lopinavir/ritonavir) of just over 10%, which now corresponds to a new formulation of Kaletra tablets. Gegeny explains that this is reasonable given the company‘s investment to develop the improved formulation that no longer requires refrigeration.

    • A price-freeze for Kaletra negotiated with state AIDS Drug Assistance Programs (ADAPs) through 2007.

    • A partnership with Baylor College of Medicine in Houston to create an international network of centers treating children with HIV.

Please or Register to post comments.

Blog Archive

Sponsored Introduction Continue on to (or wait seconds) ×